Apple has gotten another shot at the Apple Watch!
Apple has made a breakthrough in the legal dispute that forced it to recall Apple Watch models with blood oxygen sensors, due to a patent infringement battle with Masimo. After hours of not being able to sell its devices, the United States Court of Appeals for the Federal Circuit responded in favor of Apple's appeal, lifting the measure that affected the firm's smartwatches.
The result in favor of Apple will be valid until January 12, when the International Trade Commission (USITC) confirms whether the software update presented a few days ago will solve the problem or if, on the contrary, it must take other actions.
Apple gets time for the Apple Watch
This Tuesday, Apple requested a stay of the ban until Customs and Border Protection (CBP) could consider whether redesigned versions of its watcheswhich do not include the technology in dispute, violated Masimo's patents.
In October of this year, The USITC determined that Apple had infringed two patents owned by medical device maker Masimo Corporation. Likewise, those with the bitten apple were accused of insistently pursuing key personnel and taking other measures to steal technology they developed to measure oxygen levels in the blood.
In a statement given on Tuesday, Apple said: “We strongly disagree with the USITC's decision and the resulting exclusion order, and we are taking every step to return the Apple Watch Series 9 and Apple Watch Ultra 2 to customers in the US as soon as possible” .
Meanwhile, waiting for a definitive solution, At least Apple will be able to avoid the worst economic forecasts. According to JP Morgan estimates, the consequences of stopping sales of the most current Apple Watch models in the United States would represent 1% of the annual sales of the company with the bitten apple logo.
The solution that is known at this time from Apple proposes a new watchOS 10 update to modify the algorithms of the blood oxygen function (SpO2) and alter the way in which it presents the data and avoid the alleged infringement of Masimo patents.
This ban has only affected sales of the device in the United StatesFor now, all users of these devices in other parts of the world continue to have the option to update, just in time to start a new year.